On September 09, 2021 Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, reported that Chandler D. Robinson, MD, Chief Executive Officer, is scheduled to present a Company overview at the following investor conferences in September (Press release, Monopar Therapeutics, SEP 9, 2021, View Source [SID1234587480]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference
The Company’s presentation will be webcast on Monday, September 13, 2021 at 7:00 a.m. ET

Cantor Virtual Global Healthcare Conference 2021
The Company’s presentation will be webcast on Thursday, September 30, 2021 at 11:20 a.m. ET, Track 7